C15orf39

Model summary

A large soluble human scaffold that binds PRMT2-centered methyltransferase assemblies and tunes transcription indirectly. By organizing and sequestering arginine methyltransferase complexes in the cytoplasm, it modulates their availability and composition, thereby dampening transcriptional outputs. Its mechanism relies on multivalent protein-binding surfaces that assemble and regulate cytosolic regulatory complexes rather than catalyzing reactions directly.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture: the sequence is dominated end-to-end by IPR037656 (PRMT2-interacting protein family) spanning residues 1–1047.

   A single, continuous family signature that covers the entire polypeptide indicates a large, soluble scaffold rather than a modular enzyme. This architecture typically encodes extensive low-complexity and helical regions that mediate multivalent contacts with arginine methyltransferase systems, especially PRMT2-containing assemblies. Such scaffolds cause broad protein-binding capacity rather than catalysis, directly supporting GO:0005515 protein binding as the molecular function.

2. 02

   From this scaffolded binding capacity, I infer regulatory rather than enzymatic roles.

   PRMT2-centered assemblies tune transcription by coupling arginine methylation to chromatin and transcriptional machinery. A cytosolic scaffold that preferentially binds methyltransferase complexes can gate their availability and composition, thereby dampening transcriptional outputs. This causal chain—multivalent binding to PRMT2 assemblies that modulate transcription—aligns with GO:0045892 negative regulation of DNA-templated transcription as the biological process.

3. 03

   The absence of transmembrane segments and the soluble, extended architecture argue for a non-membranous localization.

   Large PRMT-associated scaffolds typically operate in the soluble compartment where assembly and trafficking of regulatory complexes occur. This points to a cytosolic residence, consistent with GO:0005829 cytosol and the broader soluble compartmentalization.

4. 04

   Mechanistically, the protein likely functions as a cytosolic hub that sequesters or chaperones PRMT2-containing complexes, buffering their cytoplasmic pools and limiting their nuclear engagement.

   By titrating PRMT2 availability and composition, the scaffold reduces the flux of arginine methylation events that promote transcriptional activation, thereby exerting negative regulation of DNA-templated transcription. I hypothesize that it transiently associates with PRMT2 and its cofactors, cytosolic chaperones that stabilize these assemblies, and cytoplasmic adaptors that control their nucleo-cytoplasmic shuttling. These interactions would collectively tune transcription indirectly through cytosolic sequestration and assembly control.